{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:44:32Z","timestamp":1786146272040,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clbc.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:32:02Z","timestamp":1782199922000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment"],"prefix":"10.1016","volume":"26","author":[{"given":"Christina","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Spadafora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hircock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing Fung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-5257","authenticated-orcid":false,"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clbc.2026.06.005_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA"},{"key":"10.1016\/j.clbc.2026.06.005_bib0002","unstructured":"Breast Cancer Statistics. Canadian Cancer Society. (2025). https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/breast\/statistics. Accessed November 15, 2025."},{"issue":"2","key":"10.1016\/j.clbc.2026.06.005_bib0003","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.suc.2013.01.002","article-title":"Radiation therapy in the management of breast cancer","volume":"93","author":"Yang","year":"2013","journal-title":"Surg Clin N Am"},{"issue":"5\u20136","key":"10.1016\/j.clbc.2026.06.005_bib0004","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/02841860310014444","article-title":"A systematic overview of radiation therapy effects in breast cancer","volume":"42","author":"Rutqvist","year":"2003","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.06.005_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.meddos.2016.06.005","article-title":"Radiation therapy for breast cancer: literature review","volume":"41","author":"Balaji","year":"2016","journal-title":"Med Dosimetry"},{"issue":"4","key":"10.1016\/j.clbc.2026.06.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1179\/jmt.2008.16.4.82E","article-title":"Clinimetrics corner: the minimal clinically important change score (MCID): a necessary pretense","volume":"16","author":"Cook","year":"2008","journal-title":"J Man Manip Ther"},{"issue":"4","key":"10.1016\/j.clbc.2026.06.005_bib0007","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-023-02157-3","article-title":"The anchor design of Anchor-based method to determine the minimal clinically important difference: a systematic review","volume":"21","author":"Zhang","year":"2023","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.clbc.2026.06.005_bib0009","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/03635465231152484","article-title":"The minimal clinically important difference changes greatly based on the different calculation methods","volume":"51","author":"Franceschini","year":"2023","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.clbc.2026.06.005_bib0010","article-title":"Establishing minimal clinically important differences for the quality of life instrument in patients with breast cancer QLICP-Br (v2.0) based on anchor-based and distribution-based methods","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.06.005_bib0011","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.22.01873","article-title":"Mepitel film for the prevention of acute radiation dermatitis in breast cancer: a randomized multicenter open-label phase III trial","volume":"41","author":"Behroozian","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2026.06.005_bib0012","article-title":"Validation of the skin symptom assessment (SSA) questionnaire for the evaluation of radiation dermatitis in breast cancer patients","volume":"32","author":"Kuszaj","year":"2024","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2026.06.005_bib0013","first-page":"1753","article-title":"Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials","volume":"19","author":"Maringwa","year":"2010","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2026.06.005_bib0014","first-page":"2731","article-title":"Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases","volume":"23","author":"Wong","year":"2015","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2026.06.005_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clbc.2026.06.005_bib0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/PROM.S256567","article-title":"Clinician and patient reporting of symptomatic adverse events in cancer clinical trials: using CTCAE and PRO-CTCAE\u00ae to provide two distinct and complementary perspectives","volume":"13","author":"Minasian","year":"2022","journal-title":"Patient Relat Outcome Meas"},{"issue":"2","key":"10.1016\/j.clbc.2026.06.005_bib0017","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpainsymman.2012.07.022","article-title":"Minimal clinically important differences in the edmonton symptom assessment system in patients with advanced cancer","volume":"46","author":"Bedard","year":"2013","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/ajco.12069","article-title":"Minimal important differences in the eortc qlq-c15-pal to determine meaningful change in palliative advanced cancer patients","volume":"12","author":"Bedard","year":"2013","journal-title":"Asia-Pac J Clin Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2026.06.005_bib0019","first-page":"3307","article-title":"An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases","volume":"20","author":"Zeng","year":"2012","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2026.06.005_bib0020","first-page":"1893","article-title":"Minimal clinically important differences in the brief pain inventory in patients with bone metastases","volume":"21","author":"Wong","year":"2013","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.005_bib0021","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-021-01228-7","article-title":"Using a distribution-based approach and systematic review methods to derive minimum clinically important differences","volume":"21","author":"Watt","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"10.1016\/j.clbc.2026.06.005_bib0022","article-title":"Correlation of CTCAE and patient-reported breast radiation dermatitis symptom scores","volume":"32","author":"Rajeswaran","year":"2024","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2026.06.005_bib0023","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.clbc.2026.06.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000006317","article-title":"Giving meaning to differences in breast-Q scores: minimal important difference for breast reconstruction patients","volume":"145","author":"Voineskos","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.clbc.2026.06.005_bib0025","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1245\/s10434-023-13222-y","article-title":"Interpreting the breast-Q for breast-conserving therapy: minimal important differences and clinical reference values","volume":"30","author":"Chu","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.06.005_bib0026","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","article-title":"A combination of distribution- and anchor-based approaches determined minimally important differences (mids) for four endpoints in a breast cancer scale","volume":"57","author":"Eton","year":"2004","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:30:57Z","timestamp":1786145457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1526820926000881"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.06.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}